Aminoguanidine protects against apoptosis of retinal ganglion cells in Zucker diabetic fatty rats

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 11, 2014, Pages 1573-1578

  Kim, J ^a   Kim, C S ^a   Sohn, E ^a   Lee, Y M ^a   Jo, K ^a   Shin, S D ^a   Kim, J S ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Advanced glycation end products; Aminoguanidine; Diabetic retinopathy; Retinal ganglion cells

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINOGUANIDINE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; GUANIDINE DERIVATIVE; IMMUNOGLOBULIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; EYE PROTECTION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; SOUTHWESTERN BLOTTING; TREATMENT DURATION; ZUCKER DIABETIC FATTY RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DRUG EFFECTS; METABOLISM; PATHOLOGY; VITREOUS BODY; ZUCKER RAT;

ANIMALS; APOPTOSIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; MALE; NF-KAPPA B; RATS; RATS, ZUCKER; RECEPTORS, IMMUNOLOGIC; RETINAL GANGLION CELLS; VITREOUS BODY;

EID: 84912041766     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mizutani M, Kern Ts, Lorenzi M. Accelerated Death Of Retinal Microvascular Cells In Human And Experimental Diabetic Retinopathy. J Clin Invest 1996; 97: 2883-2890
2. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A Role For The Polyol Pathway In The Early Neuroretinal Apoptosis And Glial Changes Induced By Diabetes In The Rat. Diabetes 2003; 52: 506-511
3. Barber Aj, Lieth E, Khin Sa, Antonetti Da, Buchanan Ag, Gardner Tw. Neural Apoptosis In The Retina During Experimental And Human Diabetes. Early Onset And Effect Of Insulin. J Clin Invest 1998; 102: 783-791
4. Brownlee M. Advanced Protein Glycosylation In Diabetes And Aging. Annu Rev Med 1995; 46: 223-234
5. Koga K, Yamagishi S, Okamoto T, Inagaki Y, Amano S, Takeuchi M, Makita Z. Serum Levels Of Glucosederived Advanced Glycation End Products Are Associated With The Severity Of Diabetic Retinopathy In Type 2 Diabetic Patients Without Renal Dysfunction. Int J Clin Pharmacol Res 2002; 22: 13-17
6. Miura J, Yamagishi S, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, Iwamoto Y. Serum Levels Of Non-Carboxymethyllysine Advanced Glycation Endproducts Are Correlated To Severity Of Microvascular Complications In Patients With Type 1 Diabetes. J Diabetes Complications 2003; 17: 16-21
7. Hammes Hp, Alt A, Niwa T, Clausen Jt, Bretzel Rg, Brownlee M, Schleicher Ed. Differential Accumulation Of Advanced Glycation End Products In The Course Of Diabetic Retinopathy. Diabetologia 1999; 42: 728-736
8. Lecleire-Collet A, Tessier Lh, Massin P, Forster V, Brasseur G, Sahel Ja, Picaud S. Advanced Glycation End Products Can Induce Glial Reaction And Neuronal Degeneration In Retinal Explants. Br J Ophthalmol 2005; 89: 1631-1633
9. Kasper M, Roehlecke C, Witt M, Fehrenbach H, Hofer A, Miyata T, Weigert C, Funk Rh, Schleicher Ed. Induction Of Apoptosis By Glyoxal In Human Embryonic Lung Epithelial Cell Line L132. Am J Respir Cell Mol Biol 2000; 23: 485-491
10. Kaji Y, Amano S, Usui T, Oshika T, Yamashiro K, Ishida S, Suzuki K, Tanaka S, Adamis Ap, Nagai R, Horiuchi S. Expression And Function Of Receptors For Advanced Glycation End Products In Bovine Corneal Endothelial Cells. Invest Ophthalmol Vis Sci 2003; 44: 521-528
11. Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M, Makita Z. Pigment Epithelium-Derived Factor Protects Cultured Retinal Pericytes From Advanced Glycation End Product-Induced Injury Through Its Antioxidative Properties. Biochem Biophys Res Commun 2002; 296: 877-882
12. Romeo G, Liu Wh, Asnaghi V, Kern Ts, Lorenzi M. Activation Of Nuclear Factor-Kappab Induced By Diabetes And High Glucose Regulates A Proapoptotic Program In Retinal Pericytes. Diabetes 2002; 51: 2241-2248
13. Kowluru Ra, Koppolu P, Chakrabarti S, Chen S. Diabetes-Induced Activation Of Nuclear Transcriptional Factor In The Retina, And Its Inhibition By Antioxidants. Free Radic Res 2003; 37: 1169-1180
14. Wu T, Chiang Sk, Chau Fy, Tso Mo. Light-Induced Photoreceptor Degeneration May Involve The Nf Kappa B/Caspase-1 Pathway In Vivo. Brain Res 2003; 967: 19-26
15. Choi Js, Kim Ja, Kim Dh, Chun Mh, Gwag Bj, Yoon Sk, Joo Ck. Failure To Activate Nf-Kappab Promotes Apoptosis Of Retinal Ganglion Cells Following Optic Nerve Transection. Brain Res 2000; 883: 60-68
16. Hammes Hp, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine Treatment Inhibits The Development Of Experimental Diabetic Retinopathy. Proc Natl Acad Sci U S A 1991; 88: 11555-11558
17. Kern Ts, Engerman Rl. Pharmacological Inhibition Of Diabetic Retinopathy: Aminoguanidine And Aspirin. Diabetes 2001; 50: 1636-1642
18. Kern Ts, Tang J, Mizutani M, Kowluru Ra, Nagaraj Rh, Romeo G, Podesta F, Lorenzi M. Response Of Capillary Cell Death To Aminoguanidine Predicts The Development Of Retinopathy: Comparison Of Diabetes And Galactosemia. Invest Ophthalmol Vis Sci 2000; 41: 3972-3978
19. Gardiner Ta, Anderson Hr, Stitt Aw. Inhibition Of Advanced Glycation End-Products Protects Against Retinal Capillary Basement Membrane Expansion During Long-Term Diabetes. J Pathol 2003; 201: 328-333
20. Vasan S, Foiles Pg, Founds Hw. Therapeutic Potential Of Age Inhibitors And Breakers Of Age Protein Cross-Links. Expert Opin Inv Drug 2001; 10: 1977-1987
21. Mitsuhashi T, Vlassara H, Founds Hw, Li Ym. Standardizing The Immunological Measurement Of Advanced Glycation Endproducts Using Normal Human Serum. J Immunol Methods 1997; 207: 79-88
22. Sohn Ej, Kim Cs, Kim Ys, Jung Dh, Jang Ds, Lee Ym, Kim Js. Effects Of Magnolol (5,5'-Diallyl-2,2'-Dihydroxybiphenyl) On Diabetic Nephropathy In Type 2 Diabetic Goto-Kakizaki Rats. Life Sci 2007; 80: 468-475
23. Hernandez-Presa Ma, Gomez-Guerrero C, Egido J. In Situ Non-Radioactive Detection Of Nuclear Factors In Paraffin Sections By Southwestern Histochemistry. Kidney Int 1999; 55: 209-214
24. Yamagishi S, Takeuchi M, Matsui T, Nakamura K, Imaizumi T, Inoue H. Angiotensin Ii Augments Advanced Glycation End Product-Induced Pericyte Apoptosis Through Rage Overexpression. Febs Lett 2005; 579: 4265-4270
25. Yamagishi S, Amano S, Inagaki Y, Okamoto T, Koga K, Sasaki N, Yamamoto H, Takeuchi M, Makita Z. Advanced Glycation End Products-Induced Apoptosis And Overexpression Of Vascular Endothelial Growth Factor In Bovine Retinal Pericytes. Biochem Biophys Res Commun 2002; 290: 973-978
26. Yamagishi S, Hsu Cc, Taniguchi M, Harada S, Yamamoto Y, Ohsawa K, Kobayashi K, Yamamoto H. Receptor-Mediated Toxicity To Pericytes Of Advanced Glycosylation End Products: A Possible Mechanism Of Pericyte Loss In Diabetic Microangiopathy. Biochem Biophys Res Commun 1995; 213: 681-687
27. Yamagishi S, Nakamura K, Matsui T. Advanced Glycation End Products (Ages) And Their Receptor (Rage) System In Diabetic Retinopathy. Curr Drug Discov Technol 2006; 3: 83-88
28. Singh R, Barden A, Mori T, Beilin L. Advanced Glycation End-Products: A Review. Diabetologia 2001; 44: 129-146
29. Engerman Rl. Pathogenesis Of Diabetic Retinopathy. Diabetes 1989; 38: 1203-1206
30. Denis U, Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M. Advanced Glycation End-Products Induce Apoptosis Of Bovine Retinal Pericytes In Culture: Involvement Of Diacylglycerol/Ceramide Production And Oxidative Stress Induction. Free Radic Biol Med 2002; 33: 236-247
31. The Effect Of Intensive Treatment Of Diabetes On The Development And Progression Of Long-Term Complications In Insulin-Dependent Diabetes Mellitus. The Diabetes Control And Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.